Skip to main content
Erschienen in: Aesthetic Plastic Surgery 1/2022

30.09.2021 | Original Article

Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach

verfasst von: Pavla Ticha, Meagan Wu, Ondrej Mestak, Andrej Sukop

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Breast reconstructive surgery is often a multistage process. The aim was to understand which factors might increase the number of follow-up surgeries and the length of time required to complete the reconstruction process.

Methods

A cross-sectional analysis was performed. Clinical data of 110 patients who underwent delayed postmastectomy breast reconstruction with a 5-year examination period were reviewed retrospectively. Impact of clinical risk factors, oncological therapy, and reconstruction approach on the number of surgeries and the length of required time was analyzed. Mann–Whitney U test and Kruskal–Wallis rank sum test were used.

Results

In patients undergoing perioperative hormone therapy, an average of 2.9 surgeries and length of 20.2 months were required compared to 2.3 surgeries and 14.0 months in patients without hormone therapy (P = 0.003; P = 0.005). Previous abdominal surgery was associated with an increased number of breast reconstruction stages of 3.1 per patient (P = 0.056) and a longer reconstruction time of 23.0 months (P = 0.050). Patients undergoing nipple reconstruction or implant revision required an increased number of surgeries (P < 0.001; P = 0.012) and a longer reconstruction time (P = 0.002; P < 0.001). Contralateral breast surgery and flap revision were associated only with an increased number of surgeries (P < 0.001; P < 0.001).

Conclusion

Perioperative hormone therapy was associated with a significantly higher number of surgeries and duration of time required to complete the reconstruction process. The highest increase in the number of surgeries was in patients with flap revision including anastomosis revision and necrectomy.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Spear SL, Mardini S, Ganz JC (2003) Resource cost comparison of implant-based breast reconstruction versus TRAM flap breast reconstruction. Plast Reconstr Surg 112:101–105CrossRef Spear SL, Mardini S, Ganz JC (2003) Resource cost comparison of implant-based breast reconstruction versus TRAM flap breast reconstruction. Plast Reconstr Surg 112:101–105CrossRef
2.
Zurück zum Zitat Wolf L (2004) The information needs of women who have undergone breast reconstruction. Part II: Information giving and content of information. Eur J Oncol Nurs 8:315–324CrossRef Wolf L (2004) The information needs of women who have undergone breast reconstruction. Part II: Information giving and content of information. Eur J Oncol Nurs 8:315–324CrossRef
3.
Zurück zum Zitat Bennett KG, Qi J, Kim HM, Hamill JB, Pusic AL, Wilkins EG (2018) Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction. JAMA Surg 153:901–908CrossRef Bennett KG, Qi J, Kim HM, Hamill JB, Pusic AL, Wilkins EG (2018) Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction. JAMA Surg 153:901–908CrossRef
4.
Zurück zum Zitat Spector DJ, Mayer DK, Knafl K, Pusic A (2011) Women’s recovery experiences after breast cancer reconstruction surgery. J Psychosoc Oncol 29:664–676CrossRef Spector DJ, Mayer DK, Knafl K, Pusic A (2011) Women’s recovery experiences after breast cancer reconstruction surgery. J Psychosoc Oncol 29:664–676CrossRef
5.
Zurück zum Zitat Eom JS, Kobayashi MR, Paydar K, Wirth GA, Evans GR (2014) The number of operations required for completing breast reconstruction. Plast Reconstr Surg Glob Open 2: e242 Eom JS, Kobayashi MR, Paydar K, Wirth GA, Evans GR (2014) The number of operations required for completing breast reconstruction. Plast Reconstr Surg Glob Open 2: e242
6.
Zurück zum Zitat Herly M, Ørholt M, Larsen A, Pipper CB, Bredgaard R, Gramkow CS, Katz AJ, Drzewiecki KT, Vester-Glowinski PV (2018) Efficacy of breast reconstruction with fat grafting: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 71:1740–1750CrossRef Herly M, Ørholt M, Larsen A, Pipper CB, Bredgaard R, Gramkow CS, Katz AJ, Drzewiecki KT, Vester-Glowinski PV (2018) Efficacy of breast reconstruction with fat grafting: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 71:1740–1750CrossRef
7.
Zurück zum Zitat Losken A, Carlson GW, Schoemann MB, Jones GE, Culbertson JH, Hester TR (2004) Factors that influence the completion of breast reconstruction. Ann Plast Surg 52:258–262CrossRef Losken A, Carlson GW, Schoemann MB, Jones GE, Culbertson JH, Hester TR (2004) Factors that influence the completion of breast reconstruction. Ann Plast Surg 52:258–262CrossRef
8.
Zurück zum Zitat Nelson JA, Voineskos SH, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL (2019) Elective Revisions after Breast Reconstruction: Results from the Mastectomy Reconstruction Outcomes Consortium. Plast Reconstr Surg 144:1280–1290CrossRef Nelson JA, Voineskos SH, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL (2019) Elective Revisions after Breast Reconstruction: Results from the Mastectomy Reconstruction Outcomes Consortium. Plast Reconstr Surg 144:1280–1290CrossRef
9.
Zurück zum Zitat Ainslie NB, Ojeda-Fournier H (1996) Creating a realistic breast: the nipple-areola reconstruction. Plast Surg Nurs 16:156–165CrossRef Ainslie NB, Ojeda-Fournier H (1996) Creating a realistic breast: the nipple-areola reconstruction. Plast Surg Nurs 16:156–165CrossRef
10.
Zurück zum Zitat Wukich DK (2015) Diabetes and its negative impact on outcomes in orthopaedic surgery. World J Orthop 6:331–339CrossRef Wukich DK (2015) Diabetes and its negative impact on outcomes in orthopaedic surgery. World J Orthop 6:331–339CrossRef
11.
Zurück zum Zitat Rifkin WJ, Kantar RS, Cammarata MJ, Wilson SC, Diaz-Siso JR, Golas AR, Levine JP, Ceradini DJ (2019) Impact of Diabetes on 30-Day Complications in Mastectomy and Implant-Based Breast Reconstruction. J Surg Res 235:148–159CrossRef Rifkin WJ, Kantar RS, Cammarata MJ, Wilson SC, Diaz-Siso JR, Golas AR, Levine JP, Ceradini DJ (2019) Impact of Diabetes on 30-Day Complications in Mastectomy and Implant-Based Breast Reconstruction. J Surg Res 235:148–159CrossRef
12.
Zurück zum Zitat Sultan SM, Seth AK, Lamelas AM, Greenspun DT, Erhard HA (2020) Bipedicle-Conjoined Deep Inferior Epigastric Perforator Flaps for Unilateral Breast Reconstruction in Overweight and Obese Patients: Do the Benefits Outweigh the Risks? J Reconstr Microsurg 36:346–352CrossRef Sultan SM, Seth AK, Lamelas AM, Greenspun DT, Erhard HA (2020) Bipedicle-Conjoined Deep Inferior Epigastric Perforator Flaps for Unilateral Breast Reconstruction in Overweight and Obese Patients: Do the Benefits Outweigh the Risks? J Reconstr Microsurg 36:346–352CrossRef
13.
14.
Zurück zum Zitat Hwang K, Son JS, Ryu WK (2018) Smoking and Flap Survival. Plast Surg (Oakv) 26:280–285CrossRef Hwang K, Son JS, Ryu WK (2018) Smoking and Flap Survival. Plast Surg (Oakv) 26:280–285CrossRef
15.
Zurück zum Zitat Dancey A, Nassimizadeh A, Levick P (2012) Capsular contracture - What are the risk factors? A 14 year series of 1400 consecutive augmentations. J Plast Reconstr Aesthet Surg 65:213–218CrossRef Dancey A, Nassimizadeh A, Levick P (2012) Capsular contracture - What are the risk factors? A 14 year series of 1400 consecutive augmentations. J Plast Reconstr Aesthet Surg 65:213–218CrossRef
16.
Zurück zum Zitat Adachi Y, Okumura S, Sawaki M et al (2020) Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction. Breast Cancer 27:716–723CrossRef Adachi Y, Okumura S, Sawaki M et al (2020) Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction. Breast Cancer 27:716–723CrossRef
17.
Zurück zum Zitat Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B (2019) Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg 144:1270–1277CrossRef Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B (2019) Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg 144:1270–1277CrossRef
18.
Zurück zum Zitat Madsen RJ, Esmonde NO, Ramsey KL, Hansen JE (2016) Axillary lymph node dissection is a risk factor for major complications after immediate breast reconstruction. Ann Plast Surg 77:513–516CrossRef Madsen RJ, Esmonde NO, Ramsey KL, Hansen JE (2016) Axillary lymph node dissection is a risk factor for major complications after immediate breast reconstruction. Ann Plast Surg 77:513–516CrossRef
19.
Zurück zum Zitat Dormand EL, Banwell PE, Goodacre TE (2005) Radiotherapy and wound healing. Int Wound J 2:112–127CrossRef Dormand EL, Banwell PE, Goodacre TE (2005) Radiotherapy and wound healing. Int Wound J 2:112–127CrossRef
20.
Zurück zum Zitat Mehanni SS, Ibrahim NF, Hassan AR, Rashed LA (2013) New approach of bone marrow-derived mesenchymal stem cells and human amniotic epithelial cells applications in accelerating wound healing of irradiated albino rats. Int J Stem Cells 6:45–54CrossRef Mehanni SS, Ibrahim NF, Hassan AR, Rashed LA (2013) New approach of bone marrow-derived mesenchymal stem cells and human amniotic epithelial cells applications in accelerating wound healing of irradiated albino rats. Int J Stem Cells 6:45–54CrossRef
21.
Zurück zum Zitat Veronesi P, Ballardini B, De Lorenzi F, Magnoni F, Lissidini G, Caldarella P, Galimberti V (2011) Immediate breast reconstruction after mastectomy. Breast 20(Suppl 3):S104-107CrossRef Veronesi P, Ballardini B, De Lorenzi F, Magnoni F, Lissidini G, Caldarella P, Galimberti V (2011) Immediate breast reconstruction after mastectomy. Breast 20(Suppl 3):S104-107CrossRef
22.
Zurück zum Zitat Williams N, Harris LN (2014) The renaissance of endocrine therapy in breast cancer. Curr Opin Obstet Gynecol 26:41–47CrossRef Williams N, Harris LN (2014) The renaissance of endocrine therapy in breast cancer. Curr Opin Obstet Gynecol 26:41–47CrossRef
23.
Zurück zum Zitat Shah MG, Maibach HI (2001) Estrogen and skin. Am J Clin Dermatol 2:143–150CrossRef Shah MG, Maibach HI (2001) Estrogen and skin. Am J Clin Dermatol 2:143–150CrossRef
24.
Zurück zum Zitat Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209–1215CrossRef Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209–1215CrossRef
25.
Zurück zum Zitat Billon R, Bosc R, Belkacemi Y, Assaf E, SidAhmed-Mezi M, Hersant B, Meningaud JP (2017) Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 70:1495–1504CrossRef Billon R, Bosc R, Belkacemi Y, Assaf E, SidAhmed-Mezi M, Hersant B, Meningaud JP (2017) Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 70:1495–1504CrossRef
26.
Zurück zum Zitat Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R. Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805–816 Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R. Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805–816
27.
Zurück zum Zitat Prandoni P (2009) Venous and arterial thrombosis: two aspects of the same disease? Clin Epidemiol 1:1–6CrossRef Prandoni P (2009) Venous and arterial thrombosis: two aspects of the same disease? Clin Epidemiol 1:1–6CrossRef
28.
Zurück zum Zitat Kelley BP, Valero V, Yi M, Kronowitz SJ (2012) Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plast Reconstr Surg 129:305–314CrossRef Kelley BP, Valero V, Yi M, Kronowitz SJ (2012) Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plast Reconstr Surg 129:305–314CrossRef
29.
Zurück zum Zitat Mirzabeigi MN, Nelson JA, Fischer JP, Kovach SJ, Serletti JM, Wu LC, Kanchwala S (2015) Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as potential perioperative thrombotic risk factors in free flap breast reconstruction. Plast Reconstr Surg 135:670–679CrossRef Mirzabeigi MN, Nelson JA, Fischer JP, Kovach SJ, Serletti JM, Wu LC, Kanchwala S (2015) Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as potential perioperative thrombotic risk factors in free flap breast reconstruction. Plast Reconstr Surg 135:670–679CrossRef
30.
Zurück zum Zitat Duggal CS, Grudziak J, Metcalfe DB, Carlson GW, Losken A (2013) The effects of breast size in unilateral postmastectomy breast reconstruction. Ann Plast Surg 70:506–512CrossRef Duggal CS, Grudziak J, Metcalfe DB, Carlson GW, Losken A (2013) The effects of breast size in unilateral postmastectomy breast reconstruction. Ann Plast Surg 70:506–512CrossRef
31.
Zurück zum Zitat Pusic AL, Matros E, Fine N, Buchel E, Gordillo GM, Hamill JB, Kim HM, Qi J, Albornoz C, Klassen AF, Wilkins EG (2017) Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol 35:2499–2506CrossRef Pusic AL, Matros E, Fine N, Buchel E, Gordillo GM, Hamill JB, Kim HM, Qi J, Albornoz C, Klassen AF, Wilkins EG (2017) Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol 35:2499–2506CrossRef
32.
Zurück zum Zitat Momeni A, Ghaly M, Gupta D, Gurtner G, Kahn DM, Karanas YL, Lee GK (2013) Nipple reconstruction after implant-based breast reconstruction: a “matched-pair” outcome analysis focusing on the effects of radiotherapy. J Plast Reconstr Aesthet Surg 66:1202–1205CrossRef Momeni A, Ghaly M, Gupta D, Gurtner G, Kahn DM, Karanas YL, Lee GK (2013) Nipple reconstruction after implant-based breast reconstruction: a “matched-pair” outcome analysis focusing on the effects of radiotherapy. J Plast Reconstr Aesthet Surg 66:1202–1205CrossRef
33.
Zurück zum Zitat Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA (2020) Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstr Aesthet Surg 73:278–285CrossRef Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA (2020) Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstr Aesthet Surg 73:278–285CrossRef
34.
Zurück zum Zitat Levine SM, Lester ME, Fontenot B, Allen RJ Sr (2011) Perforator flap breast reconstruction after unsatisfactory implant reconstruction. Ann Plast Surg 66:513–517CrossRef Levine SM, Lester ME, Fontenot B, Allen RJ Sr (2011) Perforator flap breast reconstruction after unsatisfactory implant reconstruction. Ann Plast Surg 66:513–517CrossRef
Metadaten
Titel
Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach
verfasst von
Pavla Ticha
Meagan Wu
Ondrej Mestak
Andrej Sukop
Publikationsdatum
30.09.2021
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 1/2022
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02580-1

Weitere Artikel der Ausgabe 1/2022

Aesthetic Plastic Surgery 1/2022 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.